129
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Zinc(II) and manganese(II) complexes with 1,3-bis(1-allylbenzimidazol-2-yl)-2-oxapropane: synthesis, crystal structures, antioxidant activities and DNA-binding properties

, , , , , & show all
Pages 3223-3235 | Received 04 Apr 2020, Accepted 13 Oct 2020, Published online: 09 Nov 2020
 

Abstract

Two new zinc(II) and manganese(II) complexes with the ligand 1,3-bis(1-allylbenzimidazol-2-yl)-2-oxopropane (aobb), with composition [Zn(aobb)2](pic)2·DMF·CH3OH (1) and [Mn(aobb)(DMF)2(H2O)] (pic)2 (2) (pic = picrate; DMF = N,N-dimethylformamide), have been synthesized and characterized by elemental analysis, electrical conductivities, X-ray single-crystal diffraction, IR, and UV–vis spectra. Single-crystal X-ray revealed that Zn(II) and Mn(II) centers are both located in the six-coordinate distorted octahedral geometry. The DNA-binding modes of the ligand and the complexes were investigated by electronic absorption titration, competitive binding with ethidium bromide and viscosity measurements. The experimental evidence indicated the ligand and complexes interact with calf thymus DNA through intercalation. The binding strength follows the order 2 > 1 >aobb. Additionally, 2 displays potential superoxide dismutase activity in vitro studies.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The present research was supported Foundation of A Hundred Youth Talents Training Program of Lanzhou Jiaotong University [grant number 152022]; Natural Science Foundation of Gansu Province [grant number 17JR5RA090].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.